Nevertheless, these heterogeneous and paradoxical effects of IL-10 highlight the need to better understand the roles of IL-10 in anti-tumor responses, its impact on nivolumab-induced T cell responses, and its underlying mechanisms in eliciting these effects, especially in a human experimental system. The gene discussed is IL10; the disease is neoplasm.